Publicações

Autophagy Is Required for the Therapeutic Effects of the Nad+ Precursor Nicotinamide in Obesity-Related Heart Failure with Preserved Ejection Fraction

AuthID
P-018-A81

Author(s)

Abdellatif, M

Vasques-Nóvoa, F

Trummer-Herbst, V

Durand, S

Koser, F

Islam, M

Nah, J

Sung, EA

Feng, RL

Aprahamian, F

Prokesch, A

Zardoya-Laguardia, P

Sadoshima, J

Diwan, A

Linke, WA

Ferreira, JP

Kroemer, G

Sedej, S

Tipo de Documento

Article in Press

Year published

2025

Publicado

in EUROPEAN HEART JOURNAL, ISSN: 0195-668X

Volume: 46, Número: 19, Páginas: 1863-1866 (4)

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1093/eurheartj/ehaf062

Pubmed: 39995248

SCOPUS: 2-s2.0-105005315102

Wos: WOS:001429367000001

Source Identifiers

ISSN: 0195-668X

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Autophagy Is Required for the Therapeutic Effects of the Nad+ Precursor Nicotinamide in Obesity-Related Heart Failure with Preserved Ejection Fraction

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Autophagy Is Required for the Therapeutic Effects of the Nad+ Precursor Nicotinamide in Obesity-Related Heart Failure with Preserved Ejection Fraction

Links Úteis

Ajuda